Biotech · Private company
OncoTherapy Science, Inc.
Track this companyFree. Adds OncoTherapy Science, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- OTS167IVPhase 2 · AMLClinicalTrials.gov · fetched Nov 12, 2026
- OTS167POPhase 1 · Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast CancerPHASE1 · RECRUITING · started May 29, 2017ClinicalTrials.gov NCT02926690 · fetched Nov 12, 2026
- Pharmacological Study of Intravenous OTS167 in Patients With Refractory or Relapsed Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Advanced Myelodysplastic Syndromes, Advanced Myeloproliferative Neoplastic Disorders, or Advanced Chronic Myelogenous LeukemiaPHASE1_PHASE2 · TERMINATED · started Apr 1, 2016ClinicalTrials.gov NCT02795520 · fetched Nov 12, 2026